- Global Pharma News & Resources

PressReleases - 2018-08-29

Date Title Company
29-Aug-2018 Impel NeuroPharma Annouces First Subject Dosed In Phase 1 Trial Evaluating INP105 FImpel NeuroPharma Annouces First Subject Dosed In Phase 1 Trial Evaluating INP105 For The Treatment Of Acute Agitation In Bipolar I Disorder And Schizophrenia Impel NeuroPharma
29-Aug-2018 Steward Health Care Welcomes Jim Olson As Chief Communications Officer Steward Health Care
29-Aug-2018 Skin Burns and Fire Risks From Electroshock Treatment Device, Report Warns Citizens Commission on Human Rights
29-Aug-2018 SCYNEXIS, Inc. to Participate in Upcoming Investor Conferences ed Kingdomory Board SCYNEXIS
29-Aug-2018 Government enforcement leaders team up with compliance professionals at HCCA's 4th Annual Healthcare Enforcement Compliance Conference Health Care Compliance Association
29-Aug-2018 Jill Gann Burlingame, Ph.D. is recognized by Continental Who's Who Continental Who's Who
29-Aug-2018 4medica taps Brian Keefe as new VP over company's lab orders management solutions 4medica
29-Aug-2018 Accord Healthcare Inc. Issues Voluntary Nationwide Recall of Hydrochlorothiazide Tablets USP 12.5 mg due to labeling mix-up Accord Healthcare
29-Aug-2018 MEI Pharma To Present at Wells Fargo Securities 2018 Healthcare Conference MEI Pharma
29-Aug-2018 Partners HealthCare, Neighborhood Health Plan Team Up to Offer New Telehealth Option Partners HealthCare
29-Aug-2018 Madison Street Capital Advises Rural Partners in Medicine ("RPM") on Its Partnership with Latticework Capital Management Madison Street Capital
29-Aug-2018 Daiichi Sankyo Presents First Snapshot Analyses from Global ETNA-AF Programme of Oral, Once-daily LIXIANA®? (edoxaban) in Patients with Nonvalvular Atrial Fibrillation in Routine Clinical Practice Daiichi Sankyo Company, Limited
29-Aug-2018 NeuroVive's NVP015 Program Will be Accelerated Through Award of Major Research Grant to Children's Hospital of Philadelphia on in Routine Clinical Practice NeuroVive
29-Aug-2018 Beactica Closes Financing Round to Accelerate its Pipeline of Novel Cancer Therapeutics Beactica
29-Aug-2018 BC Platforms Partners with Proteus Genomics to Realize Precision Medicine by Combining Genomic Analysis and Data Handling Technology BC Platforms
29-Aug-2018 CStone's Anti-CTLA-4 Antibody CS1002 Receives IND Approval in China CStone Pharmaceuticals
29-Aug-2018 Rex L. Mahnensmith, M.D., is recognized by Continental Who's Who Continental Who's Who
29-Aug-2018 Pioneers at Children's Hospital of Philadelphia Greet European Commission's Approval of Kymriah as Landmark Medical Advance for Young Cancer Patients in Europe Children's Hospital of Philadelphia
29-Aug-2018 Amgen Submits Supplemental New Drug Application For KYPROLIS® (carfilzomib) Once-Weekly 70 mg/m2 In Combination With Dexamethasone Amgen
29-Aug-2018 CytRx Corporation to Present at the H.C. Wainwright & Co. 20th Annual Global Investment Conference in New York City September 4-6, 2018 CytRx Corporation